Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 22280338)

1.

A survey of recent patents on CB2 agonists in the management of pain.

Murineddu G, Asproni B, Pinna GA.

Recent Pat CNS Drug Discov. 2012 Apr 1;7(1):4-24. Review.

PMID:
22280338
2.

Different classes of CB2 ligands potentially useful in the treatment of pain.

Murineddu G, Deligia F, Dore A, Pinna G, Asproni B, Pinna GA.

Recent Pat CNS Drug Discov. 2013 Apr;8(1):42-69. Review.

PMID:
23477308
3.

[The cannabinoid system and pain: towards new drugs?].

Beltramo M.

J Soc Biol. 2009;203(1):99-106. doi: 10.1051/jbio:2009002. Epub 2009 Apr 10. Review. French.

PMID:
19358815
4.

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.

Anand P, Whiteside G, Fowler CJ, Hohmann AG.

Brain Res Rev. 2009 Apr;60(1):255-66. doi: 10.1016/j.brainresrev.2008.12.003. Epub 2008 Dec 25. Review.

PMID:
19150370
5.

Cannabinoid type 2 receptor as a target for chronic - pain.

Beltramo M.

Mini Rev Med Chem. 2009 Jan;9(1):11-25. Review.

PMID:
19149657
6.

Recent data on cannabinoids and their pharmacological implications in neuropathic pain.

Coman OA, Paunescu H, Coman L, Badarau A, Fulga I.

J Med Life. 2008 Oct-Dec;1(4):365-75. Review.

PMID:
20108515
7.
8.

Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.

LaBuda CJ, Koblish M, Little PJ.

Eur J Pharmacol. 2005 Dec 19;527(1-3):172-4. Epub 2005 Nov 28.

PMID:
16316653
9.

A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.

Whiteside GT, Gottshall SL, Boulet JM, Chaffer SM, Harrison JE, Pearson MS, Turchin PI, Mark L, Garrison AE, Valenzano KJ.

Eur J Pharmacol. 2005 Dec 28;528(1-3):65-72. Epub 2005 Nov 28.

PMID:
16316650
10.

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

Malan TP Jr, Ibrahim MM, Lai J, Vanderah TW, Makriyannis A, Porreca F.

Curr Opin Pharmacol. 2003 Feb;3(1):62-7. Review.

PMID:
12550743
11.

Targeting cannabinoid agonists for inflammatory and neuropathic pain.

Cheng Y, Hitchcock SA.

Expert Opin Investig Drugs. 2007 Jul;16(7):951-65. Review.

PMID:
17594182
12.

Decahydroquinoline amides as highly selective CB2 agonists: role of selectivity on in vivo efficacy in a rodent model of analgesia.

Manley PJ, Zartman A, Paone DV, Burgey CS, Henze DA, Della Penna K, Desai R, Leitl MD, Lemaire W, White RB, Yeh S, Urban MO, Kane SA, Hartman GD, Bilodeau MT, Trotter BW.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2359-64. doi: 10.1016/j.bmcl.2011.02.078. Epub 2011 Feb 26.

PMID:
21420857
13.

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Guindon J, Hohmann AG.

Br J Pharmacol. 2008 Jan;153(2):319-34. Epub 2007 Nov 12. Review.

14.

Cannabinoid receptors and pain.

Pertwee RG.

Prog Neurobiol. 2001 Apr;63(5):569-611. Review.

PMID:
11164622
15.

Imidazopyridine CB2 agonists: optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy.

Trotter BW, Nanda KK, Burgey CS, Potteiger CM, Deng JZ, Green AI, Hartnett JC, Kett NR, Wu Z, Henze DA, Della Penna K, Desai R, Leitl MD, Lemaire W, White RB, Yeh S, Urban MO, Kane SA, Hartman GD, Bilodeau MT.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2354-8. doi: 10.1016/j.bmcl.2011.02.082. Epub 2011 Mar 1.

PMID:
21420860
16.

Latest advances in cannabinoid receptor agonists.

Thakur GA, Tichkule R, Bajaj S, Makriyannis A.

Expert Opin Ther Pat. 2009 Dec;19(12):1647-73. doi: 10.1517/13543770903436505. Review.

PMID:
19939187
18.

Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.

Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A, Malan TP Jr.

Anesthesiology. 2003 Oct;99(4):955-60.

PMID:
14508331
19.

Cannabinoids for the treatment of neuropathic pain: clinical evidence.

Ashton JC, Milligan ED.

Curr Opin Investig Drugs. 2008 Jan;9(1):65-75. Review.

PMID:
18183533
20.

CB2 cannabinoid receptor mediation of antinociception.

Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW, Porreca F, Buckley NE, Makriyannis A, Malan TP Jr.

Pain. 2006 May;122(1-2):36-42. Epub 2006 Mar 23.

PMID:
16563625
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk